# Budesonide + Glycopyrronium + Formoterol

## Breztri aerosphere 160/7.2/5mcg， 120doses

| TAH Drug Code      | [EBREZ](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EBREZ)                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Indicated for maintenance treatment of moderate to severe COPD in patients inadequately controlled on inhaled corticosteroids with long-acting bete-2 agonists or on long-acting beta-2 agonists with long-acting muscarinic antagonists.                                                                                                                                                                                                                                                                           |
| Dosing             | 2 oral inhalations (budesonide 160 mcg/glycopyrrolate 9 mcg/formoterol 4.8 mcg per inhalation) twice daily in the morning and evening; MAX， 2 inhalations twice daily.                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Hypersensitivity to budesonide， glycopyrrolate， formoterol， or any of the excipients.                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Common: Diarrhea (2.1%)， Oropharyngeal candidiasis (3%)， Backache (3.1%)， Spasm， Muscle (2.8-3.3%)， Urinary tract infectious disease (2.7%)， Cough (2.7%)， Influenza (2.9%)， Pneumonia (4.6%)， Sinusitis (2.6%)， Upper respiratory infection (5.7%). Serious: Cardiac dysrhythmia， Tachycardia， Adrenal insufficiency， Hyperglycemia， Angioedema， Hypersensitivity reaction， Decreased bone mineral density， Cataract， Glaucoma， Raised intraocular pressure， Urinary retention， Bronchospasm. |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/budesonide-and-glycopyrronium-and-formoterol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                         |

